The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open label, phase II trial of continuous low-irradiance photodynamic therapy (CLIPT) using verteporfin for the treatment of cutaneous breast cancer metastases.
 
Steven J. Isakoff
Consulting or Advisory Role - Abbvie; Merrimack; Myriad Genetics; PharmaMar
Research Funding - Abbvie; Genentech; OncoPep; PharmaMar
Travel, Accommodations, Expenses - Myriad Genetics
 
Gary S. Rogers
Employment - Rogers Sciences
Leadership - Rogers Sciences
Stock and Other Ownership Interests - Rogers Sciences
Honoraria - Rogers Sciences
Consulting or Advisory Role - Genentech
Research Funding - Rogers Sciences
Patents, Royalties, Other Intellectual Property - Rogers Sciences, Inc
 
Samuel Hill
Employment - Rogers Sciences
Leadership - Rogers Sciences
Stock and Other Ownership Interests - Rogers Sciences
Research Funding - Rogers Sciences
Patents, Royalties, Other Intellectual Property - Rogers Sciences, Inc
Travel, Accommodations, Expenses - Rogers Sciences
 
Patrick McMullan
Employment - Rogers Sciences
Stock and Other Ownership Interests - Rogers Sciences
Patents, Royalties, Other Intellectual Property - Rogers Sciences, Inc
 
Karleen R. Habin
No Relationships to Disclose
 
Hanah Park
No Relationships to Disclose
 
Diana W. Bartenstein
No Relationships to Disclose
 
Steven T Chen
No Relationships to Disclose
 
William Thomas Barry
Consulting or Advisory Role - ARMO BioSciences
Research Funding - Pfizer (Inst)
 
Beth Overmoyer
Honoraria - GTx
Research Funding - Eisai; Genentech; GTx; Incyte